US Federal House Bill HB4993

US Federal 2025-2026 Regular Session

• Introduced: 8/19/25
• Refer: 8/19/25
• Report Pass: 12/10/25

Caption

Joe Fiandra Access to Home Infusion Act of 2025

Impact

If enacted, HB4993 will significantly alter the existing framework of Medicare by broadening the types of medical equipment and drugs that are eligible for coverage. The bill specifies that home infusion therapy will be covered provided certain conditions are met, including proper administration protocols by healthcare professionals and approved medical supplies. This change is expected to alleviate some financial burdens for patients needing these therapies, ultimately enhancing the quality of at-home patient care.

Summary

House Bill 4993, known as the Joe Fiandra Access to Home Infusion Act of 2025, proposes to enhance Medicare coverage to include external infusion pumps and non-self-administrable home infusion drugs. By amending title XVIII of the Social Security Act, this bill outlines conditions under which these medical supplies would be eligible for Medicare coverage. This legislation is particularly aimed at improving access to necessary medical therapies for patients who require home-based infusion treatments, which reflects a growing trend towards offering more medical services in the home environment.

Contention

Debate surrounding HB4993 may arise as key stakeholders discuss the implications of expanded Medicare coverage. Proponents argue that this bill would recognize and address the medical needs of patients requiring home infusion therapy, potentially leading to improved health outcomes. However, potential contention may stem from concerns about the cost implications for the Medicare system, as well as how these changes will be implemented and monitored. Questions may also be raised regarding patient education about cost-sharing differences between home infusion and traditional care settings.